Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News 1st GBHI-Conference – Conference Report now available 3rd GBHI conference – program is online Who is a healthy subject? German Pharm-Tox Summit 2017 in Heidelberg 2nd part of Introductory Course in Exploratory Medicines Development scheduled for February 2017 Introductory Course in Exploratory Medicines Development – taking place in our offices in Oberursel! Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Expert Data Management Plan Adrenocortical Scientific expertise CDSIC FDA Monitoring Standardisation Quality Management System ANVISA Ophthalmological trials Endpoint Clinical Monitoring Pharmacokinetics Inhalatives Macular Training Axis EMA DPI Transdermal therapeutic system Charcoal Phase I Postmenopausal women Oncological patients IEC GCP AGAH Eye disease Project Management Immunogenicity Patients Statistical programming CDASH Auditing PASS Dry powder inhaler Pulse oximetry plethysmography Biopharmaceutics Allergy SocraTec C&S Hormone replacement therapy Uveitis Product development IB GCP training Drug Drug Interaction Local tolerability Highly variable drugs NIS SOP based Copyright Audit OTC CRO Common cold Thuringia Steady state Ophthalmology CDM CRA Biosimilars MDI Hypothalamic WinNonlin Sequential designs Paediatricians Statistical services Phase I Unit Biometrics Pragmatism Competence HRT Consultancy Phase IV In vitro in vivo correlation Feasibility Ophthalmologist Post authorisation DFI Quality Investigators brochure Patch Dermal irritation Clinical study Informed Consent Procedure Metered dose inhaler First in human Bioavailability Spacious archive Elpro CDISC Pharmacodynamic studies HPA axis Absorption Good Clinical Practice Clinical pharmacology unit Cardiovascular surveillance Intensive assessment station MMM Referral system ICF Patch adhesion Phase IIb trials DUS Recruitment rates PAES Children SAS Safety GLP Healthy subjects IVIVC Sensitisation trials Clinical trials Edema Pilot study Xerostomia TTS Network Ovulation inhibition Phase III Source Data Verification Phase II Quality Assurance Legal representative MCID Creativity Dose linearity Bioequivalence Data management Female adolescents Rhine Main area ADAM Oncologic network CRF Legal Information Oncology Protocol development Centralised procedure Statistical Analysis Plan Life cycle management Efficacy Degeneration Central surveillance system Scientific advice Dry eye Pharmacology US FDA Slit lamp microscopy Lung FIM Contraception Experience Gynaecological trials Cough Early phase Ocular tolerability Sample size estimation Phase IIa trials Pharmacokintetics Design development Non interventional SDV DDI Absorption windows Standard operating procedure IMPD Clinical development program Pituitary Patient recruitment Drug Food Interaction Inspection HTA Sore throat Database Glaucoma Authorities COPD Anaesthesiologist Biopharmaceutical Data Validation Plan Subcontractor qualification US CFR 21 Part 11 Asthma Protocol  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page